{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:26:21Z","timestamp":1740162381910,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Faculty of Pharmaceutical Sciences, Khon Kaen University","award":["Faculty of Pharmaceutical Sciences, Khon Kaen University"],"award-info":[{"award-number":["Faculty of Pharmaceutical Sciences, Khon Kaen University"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11096-023-01653-2","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T14:02:06Z","timestamp":1697464926000},"page":"101-110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5591-9565","authenticated-orcid":false,"given":"Narumol","family":"Jarernsiripornkul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somsak","family":"Tiamkao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamonphat","family":"Wongtaweepkij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teekayu Plangkoon","family":"Jorns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanjana","family":"Junsuaydee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattakan","family":"Nontasen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasina","family":"Gayrash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirinya","family":"Kampichit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"issue":"11","key":"1653_CR1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/pds.3309","volume":"21","author":"A Miguel","year":"2012","unstructured":"Miguel A, Azevedo LF, Ara\u00fajo M, et al. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2012;21(11):1139\u201354.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"1653_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40264-015-0281-0","volume":"38","author":"JC Bouvy","year":"2015","unstructured":"Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437\u201353.","journal-title":"Drug Saf"},{"key":"1653_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12883-021-02241-5","volume":"21","author":"CY Hsu","year":"2021","unstructured":"Hsu CY, Cheng CY, Lee JD, et al. Effects of long-term anti-seizure medication monotherapy on all-cause death in patients with post-stroke epilepsy: a nationwide population-based study in Taiwan. BMC Neurol. 2021;21:226.","journal-title":"BMC Neurol"},{"key":"1653_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vhri.2014.07.009","volume":"6","author":"J George","year":"2015","unstructured":"George J, Kulkarni C, Sarma GRK. Antiepileptic drugs and quality of life in patients with epilepsy: a tertiary care hospital-based study. Value Health Reg Issues. 2015;6:1\u20136.","journal-title":"Value Health Reg Issues"},{"issue":"9","key":"1653_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","volume":"11","author":"P Perucca","year":"2012","unstructured":"Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol. 2012;11(9):792\u2013802.","journal-title":"Lancet Neurol"},{"key":"1653_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40360-019-0285-y","volume":"20","author":"Y Du","year":"2019","unstructured":"Du Y, Lin J, Shen J, et al. Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015. BMC Pharmacol Toxicol. 2019;20:7.","journal-title":"BMC Pharmacol Toxicol"},{"key":"1653_CR7","doi-asserted-by":"publisher","DOI":"10.5812\/ans.112364","author":"M Maqbool","year":"2021","unstructured":"Maqbool M, Dugassa D, Fekadu G. Adverse drug reactions of antiepileptic drugs in the neurology department of a tertiary care hospital, Srinagar, Jammu & Kashmir, India. Arch Neurosci. 2021. https:\/\/doi.org\/10.5812\/ans.112364.","journal-title":"Arch Neurosci"},{"key":"1653_CR8","unstructured":"Health Product Vigialnce Center. Overview of Drug Adverse Event 1984\u20132020. 2020. https:\/\/hpvcth.fda.moph.go.th\/wp-content\/uploads\/hpvc_2021_06_08_154159.pdf. Accessed 5 Mar 2023."},{"issue":"5","key":"1653_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385\u201396.","journal-title":"Drug Saf"},{"issue":"2","key":"1653_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1365-2125.2006.02746.x","volume":"63","author":"A Blenkinsopp","year":"2007","unstructured":"Blenkinsopp A, Wilkie P, Wang M, et al. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007;63(2):148\u201356.","journal-title":"Br J Clin Pharmacol"},{"key":"1653_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2165\/11594320-000000000-00000","volume":"35","author":"F van Hunsel","year":"2012","unstructured":"van Hunsel F, H\u00e4rmark L, Pal S, et al. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf. 2012;35:45\u201360.","journal-title":"Drug Saf"},{"issue":"4","key":"1653_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s11096-023-01591-z","volume":"45","author":"L Shafei","year":"2023","unstructured":"Shafei L, Mekki L, Maklad E, et al. Factors that influence patient and public adverse drug reaction reporting: a systematic review using the theoretical domains framework. Int J Clin Pharm. 2023;45(4):801\u201313.","journal-title":"Int J Clin Pharm"},{"issue":"10","key":"1653_CR13","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/pds.2178","volume":"20","author":"J Krska","year":"2011","unstructured":"Krska J, Jones L, Mckinney J, et al. Medicine safety: experiences and perceptions of the general public in Liverpool. Pharmacoepidemiol Drug Saf. 2011;20(10):1098\u2013103.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1653_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2165\/00002018-200831060-00006","volume":"31","author":"J de Langen","year":"2008","unstructured":"de Langen J, van Hunsel F, Passier A, et al. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf. 2008;31(6):515\u201324.","journal-title":"Drug Saf"},{"issue":"4","key":"1653_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/bcp.13159","volume":"83","author":"R Al Dweik","year":"2017","unstructured":"Al Dweik R, Stacey D, Kohen D, et al. Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol. 2017;83(4):875\u201383.","journal-title":"Br J Clin Pharmacol"},{"key":"1653_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11096-020-01141-x","volume":"43","author":"H Adedeji-Adenola","year":"2021","unstructured":"Adedeji-Adenola H, Nlooto M. Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review. Int J Clin Pharm. 2021;43:11\u201324.","journal-title":"Int J Clin Pharm"},{"issue":"11","key":"1653_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s002280050571","volume":"54","author":"M Levy","year":"1999","unstructured":"Levy M, Azaz-Livshits T, Sadan B, et al. Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol. 1999;54(11):887\u201392.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"1653_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1046\/j.1365-2125.2000.00282.x","volume":"50","author":"H Bagheri","year":"2000","unstructured":"Bagheri H, Michel F, Lapeyre-Mestre M, et al. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. Br J Clin Pharmacol. 2000;50(5):479\u201384.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1653_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/clinchem\/44.5.1085","volume":"44","author":"A Warner","year":"1998","unstructured":"Warner A, Privitera M, Bates D. Standards of laboratory practice: antiepileptic drug monitoring. Clin Chem. 1998;44(5):1085\u201395.","journal-title":"Clin Chem"},{"issue":"5","key":"1653_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","volume":"40","author":"PN Patsalos","year":"2018","unstructured":"Patsalos PN, Spencer EP, Berry DJ. Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update. Ther Drug Monit. 2018;40(5):526\u201348.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"1653_CR21","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3390\/ijerph18041507","volume":"18","author":"A Valinciute-Jankauskiene","year":"2021","unstructured":"Valinciute-Jankauskiene A, Kubiliene L. Adverse drug reaction reporting by patients in 12 European countries. Int J Environ Res Public Health. 2021;18(4):1507.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"1653_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11096-015-0068-5","volume":"37","author":"N Chaipichit","year":"2015","unstructured":"Chaipichit N, Krska J, Pratipanawatr T, et al. Statin adverse effects: patients\u2019 experiences and laboratory monitoring of muscle and liver injuries. Int J Clin Pharm. 2015;37(2):355\u201364.","journal-title":"Int J Clin Pharm"},{"key":"1653_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.yebeh.2012.03.023","volume":"24","author":"N Jarernsiripornkul","year":"2012","unstructured":"Jarernsiripornkul N, Senacom P, Uchaipichat V, et al. Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy. Epilepsy Behav. 2012;24:102\u20136.","journal-title":"Epilepsy Behav"},{"key":"1653_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/pds.3871","volume":"25","author":"N Jarernsiripornkul","year":"2016","unstructured":"Jarernsiripornkul N, Chaipichit N, Pratipanawatr T, et al. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2016;25:54\u201363.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1653_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"1653_CR26","volume-title":"Harrison\u2019s principles of internal medicine","author":"DL Longo","year":"2012","unstructured":"Longo DL, Fauci AS, Kasper DL, et al. Harrison\u2019s principles of internal medicine. 18th ed. New York: McGraw-Hill; 2012. (ISBN: 978-0-071-74887-2).","edition":"18"},{"key":"1653_CR27","volume-title":"Pharmacotherapy: a pathophysiologic approach","author":"JT DiPiro","year":"2014","unstructured":"DiPiro JT, Talbert RL, Yee GC, et al. Pharmacotherapy: a pathophysiologic approach. 9th ed. New York: McGraw-Hill; 2014. (ISBN 978-0-071-85052-0).","edition":"9"},{"key":"1653_CR28","unstructured":"American Society of Health-System Pharmacists. AHFS drug information. Bethesda; 2014 (ISBN 978-1-585-28380-4)."},{"key":"1653_CR29","volume-title":"Meyler\u2019s side effects of drugs\u2014the international encyclopedia of adverse drug reactions and interactions","author":"JK Aronson","year":"2015","unstructured":"Aronson JK. Meyler\u2019s side effects of drugs\u2014the international encyclopedia of adverse drug reactions and interactions. Amsterdam: Elsevier; 2015. (ISBN 978-0-444-53716-4)."},{"issue":"Suppl 3","key":"1653_CR30","first-page":"1","volume":"102","author":"S Lertsinudom","year":"2019","unstructured":"Lertsinudom S, Nuntasaen T, Pranboon S, et al. Adverse drug reactions of antiepileptic drugs in epilepsy clinic. Srinagarind Hosp J Med Assoc Thai. 2019;102(Suppl 3):1\u20135.","journal-title":"Srinagarind Hosp J Med Assoc Thai"},{"key":"1653_CR31","doi-asserted-by":"publisher","first-page":"205031211877247","DOI":"10.1177\/2050312118772471","volume":"6","author":"MB Ayalew","year":"2018","unstructured":"Ayalew MB, Muche EA. Patient reported adverse events among epileptic patients taking antiepileptic drugs. SAGE Open Med. 2018;6:2050312118772471.","journal-title":"SAGE Open Med"},{"issue":"2","key":"1653_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/WNF.0b013e318210ece0","volume":"34","author":"S Namazi","year":"2011","unstructured":"Namazi S, Borhani-Haghighi A, Karimzadeh I. Adverse reactions to antiepileptic drugs in epileptic outpatients: a cross-sectional study in iran. Clin Neuropharmacol. 2011;34(2):79\u201383.","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"1653_CR33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11096-009-9310-3","volume":"31","author":"N Jarernsiripornkul","year":"2009","unstructured":"Jarernsiripornkul N, Chaisrisawadsuk S, Chaiyakum A, et al. Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand. Pharm World Sci. 2009;31(5):559\u201364.","journal-title":"Pharm World Sci"},{"issue":"4","key":"1653_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.7326\/0003-4819-144-4-200602210-00007","volume":"144","author":"S Bent","year":"2006","unstructured":"Bent S, Padula A, Avins AL. Brief communication: better ways to question patients about adverse medical events: a randomized, controlled trial. Ann Intern Med. 2006;144(4):257\u201361.","journal-title":"Ann Intern Med"},{"key":"1653_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/00023210-199504020-00003","volume":"4","author":"AE Bryant","year":"1995","unstructured":"Bryant AE, Dreifuss FE. Hepatotoxicity associated with antiepileptic drug therapy. CNS Drugs. 1995;4:99\u2013113. https:\/\/doi.org\/10.2165\/00023210-199504020-00003.","journal-title":"CNS Drugs"},{"issue":"Suppl 2","key":"1653_CR36","first-page":"S330","volume":"4","author":"Z Tolou-Ghamari","year":"2013","unstructured":"Tolou-Ghamari Z, Zare M, Habibabadi JM, et al. Antiepileptic drugs: a consideration of clinical and biochemical outcome in patients with epilepsy. Int J Prev Med. 2013;4(Suppl 2):S330\u20137.","journal-title":"Int J Prev Med"},{"issue":"5","key":"1653_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2176\/nmc.ra.2015-0344","volume":"56","author":"R Hanaya","year":"2016","unstructured":"Hanaya R, Arita K. The new antiepileptic drugs: their neuropharmacology and clinical indications. Neurol Med Chir. 2016;56(5):205\u201320.","journal-title":"Neurol Med Chir"},{"issue":"10","key":"1653_CR38","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/14740338.2018.1518427","volume":"17","author":"R Moavero","year":"2018","unstructured":"Moavero R, Pisani LR, Pisani F, et al. Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy. Expert Opin Drug Saf. 2018;17(10):1015\u201328.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"1653_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40801-016-0077-2","volume":"3","author":"A Hilgers","year":"2016","unstructured":"Hilgers A, Schaefer M. Systematic adverse drug reaction monitoring of patients under newer antiepileptic drugs using routine clinical data of inpatients. Drugs Real World Outcomes. 2016;3(2):209\u201321.","journal-title":"Drugs Real World Outcomes"},{"issue":"8","key":"1653_CR40","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/pds.1540","volume":"17","author":"BS Roopa","year":"2008","unstructured":"Roopa BS, Narayan SS, Sharma GRK, et al. Pattern of adverse drug reactions to antiepileptic drugs: a cross-sectional one-year survey at a tertiary care hospital. Pharmacoepidemiol Drug Saf. 2008;17(8):807\u201312.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"1653_CR41","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","volume":"49","author":"PN Patsalos","year":"2008","unstructured":"Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs - Best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008;49(7):1239\u201376.","journal-title":"Epilepsia"},{"issue":"2","key":"1653_CR42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/pds.3687","volume":"24","author":"L Rolfes","year":"2015","unstructured":"Rolfes L, van Hunsel F, Wilkes S, et al. Adverse drug reaction reports of patients and healthcare professionals-differences in reported information. Pharmacoepidemiol Drug Saf. 2015;24(2):152\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"1653_CR43","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00228-014-1653-6","volume":"70","author":"N Chaipichit","year":"2014","unstructured":"Chaipichit N, Krska J, Pratipanawatr T, et al. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. Eur J Clin Pharmacol. 2014;70(5):607\u201315.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1653_CR44","first-page":"113","volume":"33","author":"S Kampichit","year":"2018","unstructured":"Kampichit S, Pratipanawatr T, Jarernsiripornkul N. Severity of adverse drug reactions by patient self-reporting. Srinagarind Med J. 2018;33(2):113\u201321.","journal-title":"Srinagarind Med J"},{"key":"1653_CR45","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11096-014-0060-5","volume":"37","author":"J Narumol","year":"2015","unstructured":"Narumol J, Arunrot P, Krska J. Survey of patients\u2019 experiences and their certainty of suspected adverse drug reactions. Int J Clin Pharm. 2015;37:168\u201374.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"1653_CR46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.seizure.2006.02.009","volume":"15","author":"SG Uijl","year":"2006","unstructured":"Uijl SG, Uiterwaal CSMP, Aldenkamp AP, et al. A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with antiepileptic drugs. Seizure. 2006;15(4):242\u20138.","journal-title":"Seizure"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01653-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-023-01653-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01653-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T12:25:58Z","timestamp":1706703958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-023-01653-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1007\/s11096-023-01653-2","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"type":"print","value":"2210-7703"},{"type":"electronic","value":"2210-7711"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"6 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}